Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today highlighted the significance of the U.S. Food and Drug Administration's (FDA) approval of Qfitliatm (fitusiran), the sixth ...
Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...
Cardiology drug and device makers will be back in the spotlight this weekend as the annual scientific meeting of the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback